BIO-WEAPON IS POISON, ONCE IN-NO-OUT! BOTTOMLINE: SO WHY TAKE IT?

NIH Director Dr. Jay Bhattacharya on mRNA Vaccines: The Science vs. The Narrative

"The mRNA platform is promising but not yet ready for prime time as a vaccine technology. Here’s what the data actually show—free from propaganda."

1. Did It Stop Transmission?
The COVID vaccines failed to prevent infection or spread. Most vaccinated people, including Dr. Bhattacharya (vaccinated April 2021, infected June 2021), still contracted COVID. The promise of "stopping the pandemic" was unmet.

2. The mRNA Problem: Uncontrolled Antigen Factories
mRNA turns the body’s cells into spike protein producers, but critical unknowns remain:
- Dose: The actual antigen dose isn’t controlled; the "vaccine" is the spike protein, not the mRNA itself.

- Biodistribution: The lipid nanoparticles don’t stay localized; they migrate unpredictably (e.g., heart, brain).

- Off-Target Effects: Risks of aberrant protein production remain unaddressed.

3. Lives Saved? The Modeling Mirage
Claims of "14 million lives saved" rely on speculative models, not NIH data. Reality:
- Possible short-term protection for the elderly.

- Negligible benefit for the young (given COVID’s minuscule mortality risk in that group).

- Clear harms (e.g., myocarditis in young men at unacceptable rates).

Bottom Line:
For vaccines, mRNA remains experimental. For cancer? Perhaps. But the COVID rollout ignored fundamental scientific caution—with consequences we’re still untangling.